Total Payments
$108,062
2024 Payments
$29,761
Companies
7
Transactions
233
Medicare Patients
1,868
Medicare Billing
$322,517
Payment Breakdown by Category
Consulting$82,064 (75.9%)
Travel$13,016 (12.0%)
Food & Beverage$7,754 (7.2%)
Other$5,175 (4.8%)
Education$53.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $82,064 | 22 | 75.9% |
| Travel and Lodging | $13,016 | 58 | 12.0% |
| Food and Beverage | $7,754 | 144 | 7.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,175 | 1 | 4.8% |
| Education | $53.27 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $28,606 | 73 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $28,179 | 78 | $0 (2024) |
| Merck Sharp & Dohme LLC | $24,452 | 33 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $23,801 | 46 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $2,778 | 1 | $0 (2023) |
| Inari Medical, Inc. | $208.68 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $38.02 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,761 | 43 | Merck Sharp & Dohme LLC ($14,035) |
| 2023 | $20,630 | 31 | Merck Sharp & Dohme LLC ($6,786) |
| 2022 | $29,768 | 49 | Bayer HealthCare Pharmaceuticals Inc. ($11,240) |
| 2021 | $6,803 | 25 | United Therapeutics Corporation ($6,212) |
| 2020 | $3,766 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($3,504) |
| 2019 | $8,391 | 30 | Bayer HealthCare Pharmaceuticals Inc. ($6,610) |
| 2018 | $7,844 | 30 | Actelion Pharmaceuticals US, Inc. ($7,767) |
| 2017 | $1,099 | 17 | Actelion Pharmaceuticals US, Inc. ($965.26) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | United Therapeutics Corporation | — | Consulting Fee | Cash or cash equivalent | $7,540.00 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $30.99 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $30.89 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $28.42 | General |
| 11/15/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $18.94 | General |
| 11/14/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Consulting Fee | Cash or cash equivalent | $2,725.00 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $403.41 | General |
| 11/14/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $28.92 | General |
| 11/14/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $27.47 | General |
| 10/29/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $476.96 | General |
| 10/07/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $8.46 | General |
| 10/06/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $103.82 | General |
| Category: Cardiology | ||||||
| 10/05/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $89.56 | General |
| Category: Cardiology | ||||||
| 10/05/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $5,490.00 | General |
| 10/01/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 09/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $59.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $379.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $304.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $269.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | In-kind items and services | $155.91 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 416 | 586 | $323,295 | $63,008 |
| 2022 | 9 | 480 | 684 | $380,784 | $78,136 |
| 2021 | 9 | 511 | 721 | $415,922 | $90,025 |
| 2020 | 10 | 461 | 701 | $416,797 | $91,348 |
Total Patients
1,868
Total Services
2,692
Medicare Billing
$322,517
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 42 | 101 | $88,989 | $18,072 | 20.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 98 | 131 | $85,871 | $15,024 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 97 | 110 | $45,708 | $8,276 | 18.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 103 | $31,230 | $6,900 | 22.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 54 | $22,869 | $5,379 | 23.5% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 37 | 39 | $20,600 | $4,183 | 20.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 28 | $22,540 | $4,112 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 20 | $5,488 | $1,063 | 19.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 43 | 125 | $107,626 | $23,313 | 21.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 45 | $35,697 | $7,607 | 21.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 86 | $35,227 | $7,438 | 21.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 120 | $34,212 | $7,257 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 54 | 57 | $36,752 | $6,980 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 64 | 68 | $27,801 | $5,522 | 19.9% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 43 | 45 | $24,315 | $4,998 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 34 | $25,092 | $4,885 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 44 | $23,320 | $4,483 | 19.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $18,900 | $3,292 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 27 | $7,342 | $1,495 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $4,500 | $865.72 | 19.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 49 | 151 | $134,189 | $28,408 | 21.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 78 | 101 | $47,649 | $11,061 | 23.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 55 | 56 | $46,092 | $9,707 | 21.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 58 | 109 | $31,951 | $6,779 | 21.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $27,942 | $5,998 | 21.5% |
About Dr. Josanna Rodriguez-Lopez, M.D
Dr. Josanna Rodriguez-Lopez, M.D is a Pulmonary Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1780833459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Josanna Rodriguez-Lopez, M.D has received a total of $108,062 in payments from pharmaceutical and medical device companies, with $29,761 received in 2024. These payments were reported across 233 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($82,064).
As a Medicare-enrolled provider, Rodriguez-Lopez has provided services to 1,868 Medicare beneficiaries, totaling 2,692 services with total Medicare billing of $322,517. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location New York, NY
- Active Since 09/17/2008
- Last Updated 09/17/2008
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1780833459
Products in Payments
- Adempas (Drug) $22,143
- OPSUMIT (Drug) $14,733
- TYVASO (Drug) $7,273
- OPSUMIT MACITENTAN (Drug) $5,555
- UPTRAVI (Drug) $3,283
- WINREVAIR (Biological) $2,755
- ORENITRAM (Drug) $216.37
- FLOWTRIEVER CATHETER, S (Device) $208.68
- Non-Covered (Drug) $122.27
- REMICADE (Biological) $38.02
- REMODULIN (Drug) $11.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in New York
Dr. Bisher Akil, M.d, M.D
Pulmonary Disease — Payments: $452,539
Pulmonary Disease $452,539
David Rapoport, M.d, M.D
Pulmonary Disease — Payments: $366,853
Pulmonary Disease $366,853
Peter Bach, Md, MD
Pulmonary Disease — Payments: $358,604
Pulmonary Disease $358,604
Jonathan Raskin, M.d, M.D
Pulmonary Disease — Payments: $323,538
Pulmonary Disease $323,538
Roxana Sulica, M.d.,, M.D.,
Pulmonary Disease — Payments: $269,071
Pulmonary Disease $269,071
Monica Kraft
Pulmonary Disease — Payments: $235,232
Pulmonary Disease $235,232